Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (ZNTL)

Q2 2023 13F Holders as of 6/30/2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Number of holders: 129
Total Shares: 82.1M
Shares change: +15.3M
Total reported value, excl. options: $2.31B
Value change: +$442M
Put/Call ratio: 0.33
Number of buys: 93
Number of sells: -36
Price: $28.21

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.